GSK Projects
Comprehensive regulatory strategy support for GSK's vaccine divestment project and pharmaceutical operations restructuring across Sub-Saharan Africa, with specific focus on Kenya and Nigeria markets.
Challenge
GSK faced complex regulatory requirements for vaccine divestment and pharmaceutical operations restructuring across Sub-Saharan Africa. Navigating multiple jurisdictions with varying regulatory frameworks for Kenya and Nigeria required deep local expertise, strategic market analysis, and continuous compliance monitoring amid evolving regulatory landscapes.
Solution
ECP provided comprehensive regulatory intelligence and strategic guidance for GSK's vaccine divestment initiative and broader pharmaceutical operations restructuring. Our team conducted detailed market analysis, developed regulatory pathway strategies for Kenya and Nigeria, and established compliance frameworks for ongoing operations across Sub-Saharan Africa.
Results
Our involvement resulted in streamlined regulatory processes, reduced time-to-market for critical products, and enhanced compliance posture across Sub-Saharan African operations. The strategic guidance enabled GSK to navigate complex regulatory environments while maintaining operational efficiency, demonstrating ECP's capability to handle large-scale, multi-jurisdictional regulatory challenges.
- Successful vaccine divestment project management
- Comprehensive regulatory strategies for Kenya and Nigeria
- Streamlined operations restructuring across Sub-Saharan Africa
- Established robust compliance frameworks
"ECP's regulatory expertise and strategic guidance were invaluable in navigating our vaccine divestment project and operations restructuring across Sub-Saharan Africa. Their deep understanding of African regulatory landscapes and local market dynamics made complex jurisdictional challenges manageable."